Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma.

Nora DrickKatrin Milger Benjamin Seeliger Jan FugeStephanie KornRoland BuhlMaren SchuhmannFelix J F Herth Benjamin KendzioraJuergen BehrNikolaus KneidingerKarl-Christian BergmannChristian TaubeTobias WelteHendrik Suhling

Published in: Journal of asthma and allergy (2020)

Switching from anti-IL-5 to anti-IL-5Rα therapy in patients with inadequate response was associated with significantly improved FEV1, asthma control and OCS reduction.

Keyphrases

chronic obstructive pulmonary disease
lung function
early onset
binding protein